Mawson Infrastructure Group Inc. — Director's Dealing 2019

Jun 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-05-31

Reporting Person: Danenberg Noam (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-31	Warrants	$1.1	P	173607	Acquired	2021-05-30	Common Stock (173607)	Indirect

Footnotes

F1: Issued as consideration for extending by 6 months the maturity date of loans made to the Issuer.

F2: Held by Mr. Danenberg's wholly-owned company Mobigo Inc.